PARP
Poly (ADP-ribose) polymerase (PARP; EC 2.4.2.12) is found in the cell’s nucleus. The main role is to detect and signal single strand DNA breaks, preventing healthy cells from malfunctioning and programmed cell death. Cancer cells may also use PARP to repair DNA damage, thus extending their uncontrolled growth. Such cancers can become resistant to treatment (chemotherapy and/or radiation). PARP inhibitors may be especially helpful for the treatment of tumors due to genetic mutations of BRCA1 and BRCA2[1]. Human tankyrases, or TRF1-interacting ankyrin-related ADP-ribose polymerases, are specific PARPs that enhance telomerase access to telomeres, and post-translationally modify multiple proteins involved in processes including maintenance of telomere length, sister telomere association, and trafficking of glut4-containing vesicles[2],[3].
[1] A. Patel, S.H. Kaufmann. Development of PARP Inhibitors: An Unfinished Story. Oncology. 2010, 24, 66-68.
[2] Y.J. Chiang et al. Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development. PLoSONE 2008, 3, e2639.
[3] H. Seimiya. The telomeric PARP, tankyrases, as targets for cancer therapy. Br. J. Cancer. 2006, 94, 341-345.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 2537 | 1,5-Isoquinolinediol | PARP1 inhibitor and neuroprotective agent | €50.00 | |
| 1496 | 3-Aminobenzamide | Competitive small molecule inhibitor of PARP | €40.00 | |
| 1529 | AG 014699 | PARP1 inhibitor | €60.00 | |
| 2241 | AZD2461 | PARP inhibitor with poor P-glycoprotein substrate qualities | €95.00 | |
| 1268 | DR 2313 | PARP inhibitor | €90.00 | |
| 3398 | E7449 mesylate | Potent, brain penetrable and orally bioavailable dual inhibitor of PARP1/2 and TNKS1/2 | €110.00 | |
| 2885 | GeA-69 | Selective allosteric and cell-active PARP14 MD2 inhibitor | €95.00 | |
| 1566 | Iniparib | PARP inhibitor | €60.00 | |
| 4179 | KU-0058948 | Potent and specific PARP1 inhibitor | Recently added | €135.00 |
| 2001 | KU-0058948 hydrochloride | Potent and specific PARP1 inhibitor | €135.00 | |
| 2759 | ME0328 | PARP3/ARTD3 inhibitor | €95.00 | |
| 2928 | Niraparib | Potent, selective, and orally available PARP1/2 inhibitor | €90.00 | |
| 1370 | NU 1025 | PARP inhibitor | €80.00 | |
| 1464 | Olaparib | PARP inhibitor | €50.00 | |
| 3113 | Rucaparib camsylate | PARP1 inhibitor | €90.00 | |
| 2502 | Talazoparib | Potent, selective, and orally available PARP1/2 inhibitor | €90.00 | |
| 2369 | UPF 1069 | PARP-2 inhibitor with >26 fold selectivity over PARP1 | €75.00 | |
| 1593 | Veliparib | PARP inhibitor | €40.00 | |
| 2888 | Veliparib dihydrochloride | PARP inhibitor | €95.00 | |